Skip to main content

Advertisement

SpringerLink
Log in

Insulinoma—Accurate Preoperative Localization Is the Key to Management: An Initial Experience

  • Original Article
  • Published:
Indian Journal of Surgical Oncology Aims and scope Submit manuscript

Abstract

Insulinoma is the commonest functioning pancreatic neuroendocrine tumor. The only curative treatment is surgical excision after preoperative localization. A retrospective analysis of nine patients (February 2017–June 2020), 2 males and 7 females, was done for clinical presentation, biochemistry, localization methods, intraoperative findings, postoperative outcome, histopathology reports, and follow-up. Techniques for localization of the tumor were pancreatic protocol triple-phase multi-detector computed tomography (MDCT), endoscopic ultrasound (EUS), Ga 68 DOTANOC PET-CT, and Ga 68 NOTA-exendin-4 PET-CT (GLP1R scan). The mean age was 38 (range 20–68) years and mean duration of symptoms 34 (range 8–120) months, and symptoms of Whipple’s triad were present in all cases after a supervised 72-h fast. MDCT localized tumor in 8/9 cases. EUS before MDCT in one patient had also localized tumors. Ga 68 DOTANOC PET-CT detected tumor in 2/4 patients. In one patient, MDCT or DOTANOC PET scan could not localize tumor; GLP1R scan localized tumor accurately. Two patients had associated MEN1 syndrome. All 9 patients underwent surgical resection (four open and five laparoscopic) of tumor-enucleation (3), distal pancreatectomy with splenectomy (3), and pancreatoduodenectomy (PD) (3). The last four procedures and all three enucleations were laparoscopic. Five patients developed postoperative pancreatic fistula (POPF), only one grade B which required percutaneous drain placement. One patient, who had initial open enucleation, developed hypoglycemia after 48 h; PD was performed. All patients were cured and all, except one (who died of upper GI bleed), were alive and disease-free during a mean follow-up of 26 (range 2–41) months. Preoperative localization of insulinoma is important and decides the outcome of surgery in terms of cure. MDCT can localize tumors in most patients; the last resort for localization is the GLP1R scan. Laparoscopic procedures are equally effective compared to open surgery. Considering the benign nature of the disease, enucleation is the procedure of choice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Grant CS (2005) Insulinoma. Best Pract Res Clin Gastroenterol 19(5):783–798

    CAS  PubMed  Google Scholar 

  2. Halfdanarson TR, Rubin J, Farnell MB, Grant CS, Petersen GM (2008) Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors. Endocr Relat Cancer 15(2):409

    PubMed  PubMed Central  Google Scholar 

  3. Ito T, Igarashi H, Jensen RT (2012) Pancreatic neuroendocrine tumors: clinical features, diagnosis and medical treatment: advances. Best Pract Res Clin Gastroenterol 26(6):737–753

    PubMed  PubMed Central  Google Scholar 

  4. Öberg K, Eriksson B (2005) Endocrine tumours of the pancreas. Best Pract Res Clin Gastroenterol 19(5):753–781

    PubMed  Google Scholar 

  5. Sotoudehmanesh R, Hedayat A, Shirazian N, Shahraeeni S, Ainechi S, Zeinali F, Kolahdoozan S (2007) Endoscopic ultrasonography (EUS) in the localization of insulinoma. Endocrine 31(3):238–241

    CAS  PubMed  Google Scholar 

  6. Okabayashi T, Shima Y, Sumiyoshi T, Kozuki A, Ito S, Ogawa Y, Kobayashi M, Hanazaki K (2013) Diagnosis and management of insulinoma. World J Gastroenterol: WJG 19(6):829–837

    PubMed  PubMed Central  Google Scholar 

  7. Paul TV, Jacob JJ, Vasan SK, Thomas N, Rajarathnam S, Selvan B, Paul MJ, Abraham D, Nair A, Seshadri MS (2008) Management of insulinomas: analysis from a tertiary care referral center in India. World J Surg 32(4):576–582

    PubMed  Google Scholar 

  8. Gopal RA, Acharya SV, Menon SK, Bandgar TR, Menon PS, Shah NS (2010) Clinical profile of insulinoma: analysis from a tertiary care referral center in India. Indian J Gastroenterol 29(5):205–208

    PubMed  Google Scholar 

  9. Jyotsna VP, Rangel N, Pal S, Seith A, Sahni P, Ammini AC (2006) Insulinoma: diagnosis and surgical treatment Retrospective analysis of 31 cases. Indian J Gastroenterol. 25(5):244

    PubMed  Google Scholar 

  10. Jyotsna VP, Pal S, Kandasamy D, Gamanagatti S, Garg PK, Raizada N, Sahni P, Bal CS, Tandon N, Ammini AC (2016) Evolving management of insulinoma: experience at a tertiary care centre. Indian J Med Res 144(5):771

    PubMed  PubMed Central  Google Scholar 

  11. Hsien-chiu T, Chong-zheng Y, Shou-xian Z, Jian-xi Z, Yu Z (1984) Percutaneous transhepatic portal vein catheterization for localization of insulinoma. World J Surg 8(4):575–581

    Google Scholar 

  12. Bassi C, Marchegiani G, Dervenis C, Sarr M, Abu Hilal M, Adham M, Allen P, Andersson R, Asbun HJ, Besselink MG, Conlon K, International Study Group on Pancreatic Surgery (ISGPS) (2017) The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 years after. Surgery. 161(3):584–91

    PubMed  Google Scholar 

  13. Iglesias P, Díez JJ (2014) Management of endocrine disease: a clinical update on tumor-induced hypoglycemia. Eur J Endocrinol 170(4):R147–R157

    CAS  PubMed  Google Scholar 

  14. Valente LG, Antwi K, Nicolas GP, Wild D, Christ E (2018) Clinical presentation of 54 patients with endogenous hyperinsulinaemic hypoglycemia: a neurological chameleon (observational study). Swiss Med Wkly 148:w14682. https://doi.org/10.4414/smw.2018.14682

    Article  CAS  PubMed  Google Scholar 

  15. Jagadheesan V, Suresh SS (2008) Episodic confusional state: due to insulinoma. Indian J Psychiatry 50(3):197

    PubMed  PubMed Central  Google Scholar 

  16. Boukhman MP, Karam JH, Shaver J, Siperstein AE, Duh QY, Clark OH (1998) Insulinoma–experience from 1950 to 1995. West J Med 169(2):98

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Service FJ (1995) Hypoglycemic disorders. N Engl J Med 332(17):1144–1152

    PubMed  Google Scholar 

  18. Cryer PE, Axelrod L, Grossman AB, Heller SR, Montori VM, Seaquist ER, Service FJ (2009) Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 94(3):709–28

    CAS  PubMed  Google Scholar 

  19. Guettier JM, Kam A, Chang R, Skarulis MC, Cochran C, Alexander HR, Libutti SK, Pingpank JF, Gorden P (2009) Localization of insulinomas to regions of the pancreas by intraarterial calcium stimulation: the NIH experience. J Clin Endocrinol Metab 94(4):1074–1080

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Abboud B, Boujaoude J (2008) Occult sporadic insulinoma: localization and surgical strategy. World J Gastroenterol: WJG 14(5):657

    PubMed  PubMed Central  Google Scholar 

  21. Van Nieuwenhove Y, Vandaele S, de Beeck BO, Delvaux G (2003) Neuroendocrine tumors of the pancreas. Surgical Endoscopy And Other Interventional Techniques 17(10):1658–1662

    PubMed  Google Scholar 

  22. Service FJ, McMahon MM, O’Brien PC, Ballard DJ (1991) Functioning insulinoma—incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc 66(7):711–719

    CAS  PubMed  Google Scholar 

  23. Falconi M, Mantovani W, Crippa S, Mascetta G, Salvia R, Pederzoli P (2008) Pancreatic insufficiency after different resections for benign tumours. J Br Surg 95(1):85–91

    CAS  Google Scholar 

  24. Gupta RA, Patel RP, Nagral S (2013) Adult onset nesidioblastosis treated by subtotal pancreatectomy. JOP 14(3):286–288

    PubMed  Google Scholar 

  25. Doppman JL, Chang R, Fraker DL, Norton JA, Alexander HR, Miller DL, Collier E, Skarulis MC, Gorden P (1995) Localization of insulinomas to regions of the pancreas by intra-arterial stimulation with calcium. Ann Intern Med 123(4):269–273

    CAS  PubMed  Google Scholar 

  26. Luo Y, Pan Q, Yao S, Yu M, Wu W, Xue H, Kiesewetter DO, Zhu Z, Li F, Zhao Y, Chen X (2016) Glucagon-like peptide-1 receptor PET/CT with 68Ga-NOTA-exendin-4 for detecting localized insulinoma: a prospective cohort study. J Nucl Med 57(5):715–720

    CAS  PubMed  Google Scholar 

  27. De Herder WW, Niederle B, Scoazec JY, Pauwels S, Klöppel G, Falconi M, Kwekkeboom DJ, Öberg K, Eriksson B, Wiedenmann B, Rindi G (2006) Well-differentiated pancreatic tumor/carcinoma: insulinoma. Neuroendocrinology 84(3):183–188

    PubMed  Google Scholar 

  28. Mathur A, Gorden P, Libutti SK (2009) Insulinoma. Surg Clin 89(5):1105–1121

    Google Scholar 

  29. An L, Li W, Yao KC, Liu R, Lv F, Tang J, Zhang S (2011) Assessment of contrast-enhanced ultrasonography in diagnosis and preoperative localization of insulinoma. Eur J Radiol 80(3):675–680

    PubMed  Google Scholar 

  30. Wang H, Ba Y, Xing Q, Du JL (2018) Diagnostic value of endoscopic ultrasound for insulinoma localization: a systematic review and meta-analysis. PLoS ONE 13(10):e0206099

    PubMed  PubMed Central  Google Scholar 

  31. McLean A (2004) Endoscopic ultrasound in the detection of pancreatic islet cell tumours. Cancer Imaging 4(2):84

    PubMed  PubMed Central  Google Scholar 

  32. Burghardt L, Meier JJ, Uhl W, Kahle-Stefan M, Schmidt WE, Nauck MA (2019) Importance of localization of insulinomas: a systematic analysis. J Hepatobiliary Pancreat Sci 26(9):383–392

    PubMed  Google Scholar 

  33. Fidler JL, Fletcher JG, Reading CC, Andrews JC, Thompson GB, Grant CS, Service FJ (2003) Preoperative detection of pancreatic insulinomas on multiphasic helical CT. Am J Roentgenol. 181(3):775–80

    CAS  Google Scholar 

  34. Gouya H, Vignaux O, Augui J, Dousset B, Palazzo L, Louvel A, Chaussade S, Legmann P (2003) CT, endoscopic sonography, and a combined protocol for preoperative evaluation of pancreatic insulinomas. Am J Roentgenol 181(4):987–992

    Google Scholar 

  35. McAuley G, Delaney H, Colville J, Lyburn I, Worsley D, Govender P, Torreggiani WC (2005) Multimodality preoperative imaging of pancreatic insulinomas. Clin Radiol 60(10):1039–1050

    CAS  PubMed  Google Scholar 

  36. Noone TC, Hosey J, Firat Z, Semelka RC (2005) Imaging and localization of islet-cell tumours of the pancreas on CT and MRI. Best Pract Res Clin Endocrinol Metab 19(2):195–211

    PubMed  Google Scholar 

  37. Balci NC, Semelka RC (2001) Radiologic diagnosis and staging of pancreatic ductal adenocarcinoma. Eur J Radiol 38(2):105–112

    CAS  PubMed  Google Scholar 

  38. Kurosaki Y, Kuramoto K, Itai Y (1996) Hyperattenuating insulinoma at unenhanced CT. Abdom Imaging 21(4):334–336

    CAS  PubMed  Google Scholar 

  39. Antwi K, Fani M, Heye T, Nicolas G, Rottenburger C, Kaul F, Merkle E, Zech CJ, Boll D, Vogt DR, Gloor B (2018) Comparison of glucagon-like peptide-1 receptor (GLP-1R) PET/CT, SPECT/CT and 3T MRI for the localisation of occult insulinomas: evaluation of diagnostic accuracy in a prospective crossover imaging study. Eur J Nucl Med Mol Imaging 45(13):2318–2327

    CAS  PubMed  Google Scholar 

  40. Öberg K (2010) Pancreatic endocrine tumors. In Seminars in oncology. 37(6):594–618). WB Saunders

  41. Tsang YP, Lang BH, Shek TW (2016) Assessing the short-and long-term outcomes after resection of benign insulinoma. ANZ J Surg 86(9):706–710

    PubMed  Google Scholar 

  42. Kann P, Moll R, Bartsch D, Pfützner A, Forst T, Tamagno G, Goebel J, Fourkiotis V, Bergmann S, Collienne M (2017) Endoscopic ultrasound-guided fine-needle aspiration biopsy (EUS-FNA) in insulinomas: indications and clinical relevance in a single investigator cohort of 47 patients. Endocrine (1355008X) 56(1)

  43. Luigiano C, Ferrara F, Morace C, Mangiavillano B, Fabbri C, Cennamo V, Bassi M, Virgilio C, Consolo P (2012) Endoscopic tattooing of gastrointestinal and pancreatic lesions. Adv Ther 29(10):864–873

    PubMed  Google Scholar 

  44. Joseph AJ, Kapoor N, Simon EG, Chacko A, Thomas EM, Eapen A, Abraham TD, Jacob PM, Paul T, Rajaratnam S, Thomas N (2013) Endoscopic ultrasonography-a sensitive tool in the preoperative localization of insulinoma. Endocr Pract 19(4):602–608

    CAS  PubMed  Google Scholar 

  45. Challis BG, Powlson AS, Casey RT, Pearson C, Lam BY, Ma M, Pitfield D, Yeo GS, Godfrey E, Cheow HK, Chatterjee VK (2017) Adult-onset hyperinsulinaemic hypoglycaemia in clinical practice: diagnosis, aetiology and management. Endocr Connect 6(7):540–548

    CAS  PubMed  PubMed Central  Google Scholar 

  46. Lo CY, Lam KY, Kung AW, Lam KS, Tung PH, Fan ST (1997) Pancreatic insulinomas: a 15-year experience. Arch Surg 132(8):926–930

    CAS  PubMed  Google Scholar 

  47. Rothmund M, Angelini L, Brunt LM, Farndon JR, Geelhoed G, Grama D, Herfarth C, Kaplan EL, Largiader F, Morino F, Peiper HJ (1990) Surgery for benign insulinoma: an international review. World J Surg 14(3):393–398

    CAS  PubMed  Google Scholar 

  48. Korner M, Christ E, Wild D, Reubi JC (2012) Glucagon-like peptide-1 receptor overexpression in cancer and its impact on clinical applications. Front Endocrinol (Lausanne) 3:158

    Google Scholar 

  49. Portela-Gomes GM, Stridsberg M, Grimelius L, Rorstad O, Janson ET (2007) Differential expression of the five somatostatin receptor subtypes in human benign and malignant insulinomas–predominance of receptor subtype 4. Endocr Pathol 18(2):79–85

    CAS  PubMed  Google Scholar 

  50. Falconi M, Eriksson B, Kaltsas G, Bartsch DK, Capdevila J, Caplin M, Kos-Kudla B, Kwekkeboom D, Rindi G, Klöppel G, Reed N (2016) ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors. Neuroendocrinology 103(2):153–171

    CAS  PubMed  Google Scholar 

  51. Luo Y, Yu M, Pan Q, Wu W, Zhang T, Kiesewetter DO, Zhu Z, Li F, Chen X, Zhao Y (2015) ^ sup 68^ Ga-NOTA-exendin-4 PET/CT in detection of occult insulinoma and evaluation of physiological uptake. Eur J Nucl Med Mol Imaging 42(3):531

    PubMed  Google Scholar 

  52. Sharma P, Arora S, Dhull VS, Naswa N, Kumar R, Ammini AC, Bal C (2015) Evaluation of 68 Ga-DOTANOC PET/CT imaging in a large exclusive population of pancreatic neuroendocrine tumors. Abdom Imaging 40(2):299–309

    PubMed  Google Scholar 

  53. Prasad V, Sainz-Esteban A, Arsenic R, Plöckinger U, Denecke T, Pape UF, Pascher A, Kühnen P, Pavel M, Blankenstein O (2016) Role of 68 Ga somatostatin receptor PET/CT in the detection of endogenous hyperinsulinaemic focus: an explorative study. Eur J Nucl Med Mol Imaging 43(9):1593–1600

    CAS  PubMed  Google Scholar 

  54. Nockel P, Babic B, Millo C, Herscovitch P, Patel D, Nilubol N, Sadowski SM, Cochran C, Gorden P, Kebebew E (2017) Localization of insulinoma using 68Ga-DOTATATE PET/CT scan. J Clin Endocrinol Metab 102(1):195–199

    PubMed  Google Scholar 

  55. Sharma P, Arora S, Karunanithi S, Khadgawat R, Durgapal P, Sharma R, Kandasamy D, Bal C, Kumar R (2014) Somatostatin receptor based PET/CT imaging with 68Ga-DOTA-Nal3-octreotide for localization of clinically and biochemically suspected insulinoma. Q J Nucl Med Mol Imaging 60(1):69–76

    PubMed  Google Scholar 

  56. Brown E, Watkin D, Evans J, Yip V, Cuthbertson DJ (2018) Multidisciplinary management of refrsactory insulinomas. Clin Endocrinol 88(5):615–624

    Google Scholar 

  57. Shin JJ, Gorden P, Libutti SK (2010) Insulinoma: pathophysiology, localization and management. Future Oncol 6(2):229–237

    CAS  PubMed  Google Scholar 

  58. Placzkowski KA, Vella A, Thompson GB, Grant CS, Reading CC, Charboneau JW, Andrews JC, Lloyd RV, Service FJ (2009) Secular trends in the presentation and management of functioning insulinoma at the Mayo Clinic, 1987–2007. J Clin Endocrinol Metab 94(4):1069–73

    CAS  PubMed  Google Scholar 

  59. Nikfarjam M, Warshaw AL, Axelrod L, Deshpande V, Thayer SP, Ferrone CR, Fernández-del CC (2008) Improved contemporary surgical management of insulinomas: a 25-year experience at the Massachusetts General Hospital. Ann Surg 247(1):165

    PubMed  Google Scholar 

  60. Goh BK, Ooi LL, Cheow PC, Tan YM, Ong HS, Chung YF, Chow PK, Wong WK, Soo KC (2009) Accurate preoperative localization of insulinomas avoids the need for blind resection and reoperation: analysis of a single institution experience with 17 surgically treated tumors over 19 years. J Gastrointest Surg 13(6):1071–1077

    PubMed  Google Scholar 

  61. Fernández-Cruz L, Cesar-Borges G (2006) Laparoscopic strategies for resection of insulinomas. J Gastrointest Surg 10(5):752–760

    PubMed  Google Scholar 

  62. Witteles RM, Straus FH II, Sugg SL, Koka MR, Costa EA, Kaplan EL (2001) Adult-onset nesidioblastosis causing hypoglycemia: an important clinical entity and continuing treatment dilemma. Arch Surg 136(6):656–663

    CAS  PubMed  Google Scholar 

  63. Anlauf M, Wieben D, Perren A, Sipos B, Komminoth P, Raffel A, Kruse ML, Fottner C, Knoefel WT, Mönig H, Heitz PU (2005) Persistent hyperinsulinemic hypoglycemia in 15 adults with diffuse nesidioblastosis: diagnostic criteria, incidence, and characterization of β-cell changes. Am J Surg Pathol 29(4):524–533

    PubMed  Google Scholar 

  64. Toyomasu Y, Fukuchi M, Yoshida T, Tajima K, Osawa H, Motegi M, Iijima T, Nagashima K, Ishizaki M, Mochiki E, Kuwano H (2009) Treatment of hyperinsulinemic hypoglycemia due to diffuse nesidioblastosis in adults: a case report. Am Surg 75(4):331–334

    PubMed  Google Scholar 

  65. Klöppel G, Anlauf M, Raffel A, Perren A, Knoefel WT (2008) Adult diffuse nesidioblastosis: genetically or environmentally induced? Hum Pathol 39(1):3–8

    PubMed  Google Scholar 

  66. Klöppel G, Anlauf M (2006) Pancreatic endocrine tumors. AJSP: Rev Rep 11(6):256–67

  67. Callender GG, Rich TA, Perrier ND (2008) Multiple endocrine neoplasia syndromes. Surg Clin North Am 88(4):863–895

    PubMed  Google Scholar 

  68. Jani N, Moser AJ, Khalid A (2007) Pancreatic endocrine tumors. Gastroenterol Clin North Am 36(2):431–439

    PubMed  Google Scholar 

  69. Antonakis PT, Ashrafian H, Martinez-Isla A (2015) Pancreatic insulinomas: laparoscopic management. World J Gastrointest Endosc 7(16):1197

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgical Gastroenterology, Mahatma Gandhi Medical College and Hospital, Jaipur, 302022, India

    Ajay Sharma, Krishnavardhan Venkatatelikicherla & R. P. Choubey

  2. Department of Surgical Gastroenterology, All India Institute of Medical Sciences, Jodhpur, 342005, India

    Peeyush Varshney

  3. Department of Endocrinology, Mahatma Gandhi Medical College and Hospital, Jaipur, 302022, India

    Rajeev Kasliwal

  4. Department of Hepato Pancreato Biliary Surgery, Mahatma Gandhi Medical College and Hospital, Jaipur, 302022, India

    Anand Nagar, Shashwat Sarin & V. K. Kapoor

Authors
  1. Ajay Sharma
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peeyush Varshney
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rajeev Kasliwal
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Anand Nagar
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Krishnavardhan Venkatatelikicherla
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Shashwat Sarin
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. R. P. Choubey
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. V. K. Kapoor
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anand Nagar.

Ethics declarations

Competing Interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sharma, A., Varshney, P., Kasliwal, R. et al. Insulinoma—Accurate Preoperative Localization Is the Key to Management: An Initial Experience. Indian J Surg Oncol 13, 403–411 (2022). https://doi.org/10.1007/s13193-022-01534-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13193-022-01534-6

Keywords

Search

Navigation